Answer
The groundbreaking CRISPR-Cas9 gene-editing tool was first conceptualized in 2012 by the pioneering scientists Emmanuelle Charpentier and Jennifer A. Doudna. This revolutionary system harnesses the natural defense mechanism found in bacteria to precisely target and modify specific segments of DNA, offering immense potential for genetic research and therapeutic applications.